Cite
Antibody seroconversion in asymptomatic and symptomatic patients infected with severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2).
MLA
Jiang, Chuanhao, et al. “Antibody Seroconversion in Asymptomatic and Symptomatic Patients Infected with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS‐CoV‐2).” Clinical & Translational Immunology, vol. 9, no. 9, Sept. 2020, pp. 1–14. EBSCOhost, https://doi.org/10.1002/cti2.1182.
APA
Jiang, C., Wang, Y., Hu, M., Wen, L., Wen, C., Wang, Y., Zhu, W., Tai, S., Jiang, Z., Xiao, K., Faria, N. R., De Clercq, E., Xu, J., & Li, G. (2020). Antibody seroconversion in asymptomatic and symptomatic patients infected with severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2). Clinical & Translational Immunology, 9(9), 1–14. https://doi.org/10.1002/cti2.1182
Chicago
Jiang, Chuanhao, Yali Wang, Min Hu, Lingjun Wen, Chuan Wen, Yang Wang, Weihong Zhu, et al. 2020. “Antibody Seroconversion in Asymptomatic and Symptomatic Patients Infected with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS‐CoV‐2).” Clinical & Translational Immunology 9 (9): 1–14. doi:10.1002/cti2.1182.